Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-17 Sale | 2021-06-21 5:28 pm | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 27,497 | $168.67 | $4,637,811 | 105,780 (Direct) | View |
| 2021-06-15 Sale | 2021-06-17 8:50 pm | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 28,866 | $167.41 | $4,832,342 | 246,332 (Direct) | View |
| 2021-06-01 Sale | 2021-06-03 4:02 pm | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 850 | $170.45 | $144,883 | 56,128 (Direct) | View |
| 2021-01-08 Sale | 2021-01-11 4:26 pm | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 3,136 | $130.04 | $407,805 | 34,500 (Direct) | View |
| 2020-08-13 Sale | 2020-08-17 4:17 pm | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 1,364 | $102.88 | $140,328 | 37,636 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-07-01 Disposition | 2021-07-01 6:29 pm | N/A 2028-08-10 | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 125,435 | $0 | 0 (Direct) | View |
| 2021-06-17 Exercise | 2021-06-21 5:28 pm | N/A N/A | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 18,958 | $101.42 | 105,780 (Direct) | View |
| 2021-06-17 Exercise | 2021-06-21 5:28 pm | N/A N/A | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 4,213 | $95.94 | 105,780 (Direct) | View |
| 2021-06-17 Exercise | 2021-06-21 5:28 pm | N/A N/A | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 4,326 | $103.3 | 105,780 (Direct) | View |
| 2021-06-17 Exercise | 2021-06-21 5:28 pm | N/A 2029-08-13 | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 27,497 | $0 | 105,780 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 8:50 pm | N/A N/A | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 18,542 | $101.42 | 246,332 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 8:50 pm | N/A N/A | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 4,121 | $95.94 | 246,332 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 8:50 pm | N/A N/A | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 4,230 | $103.3 | 246,332 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 8:50 pm | N/A 2028-08-10 | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 26,893 | $0 | 246,332 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 4:02 pm | N/A N/A | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 16,831 | $0 | 56,128 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-03 4:02 pm | N/A N/A | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, CAO & General Counsel | 2,823 | $0 | 56,128 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-03 4:18 pm | N/A N/A | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, Chf Admin Ofcr & Gen Coun | 34,140 | $0 | 34,140 (Direct) | View |
Ownership | 2020-03-05 4:18 pm | N/A N/A | PRA Health Sciences Inc. | PRAH | Gaenzle Christopher L EVP, Chief Admin Officer & GC | 0 | $0 | 139,000 (Direct) | View |